Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study
Aruna D Pradhan, Nina P Paynter, Brendan M Everett, Robert J Glynn, Pierre Amarenco, Marshall Elam, Henry Ginsberg, William R Hiatt, Shun Ishibashi, Wolfgang Koenig, Børge G Nordestgaard, Jean-Charles Fruchart, Peter Libby, Paul M Ridker
Dyk ned i forskningsemnerne om 'Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study'. Sammen danner de et unikt fingeraftryk.
Keyphrases
Pharmacology, Toxicology and Pharmaceutical Science